Skip to content
EVANIUM logo
  • OPTISOLV® Technology
    • How OPTISOLV® works
    • Whitepaper
  • Ingredients
    • OPTISOLV® Berberine
    • OPTISOLV® Boswellia
    • OPTISOLV® Curcumin
    • OPTISOLV® Passiflora
  • Applications
    • Nutraceuticals
    • Pharmaceuticals
    • Functional foods
    • Cosmetics
  • Company
    • Team
    • Careers
    • Board of investors
  • News
    • Press
  • Request samples
  • OPTISOLV® Technology
    • How OPTISOLV® works
    • Whitepaper
  • Ingredients
    • OPTISOLV® Berberine
    • OPTISOLV® Boswellia
    • OPTISOLV® Curcumin
    • OPTISOLV® Passiflora
  • Applications
    • Nutraceuticals
    • Pharmaceuticals
    • Functional foods
    • Cosmetics
  • Company
    • Team
    • Careers
    • Board of investors
  • News
    • Press
  • Request samples
Request samples

Day: April 14, 2026

EVANIUM Raises €2.2 Million Seed Round to Solve One of the Most Expensive Inefficiencies in the Nutraceutical Industry

The EVANIUM team at the BioPark Regensburg

FoodLabs and Feast Ventures back OPTISOLV® Technology. The €2.2 million seed round accelerates EVANIUM’s ingredient platform, clinical validation and market expansion.

EVANIUM logo

Unlock the full potential of ingredients. Developed in Germany, produced in France.

EVANIUM Healthcare GmbH
Am Biopark 13
93053 Regensburg, Germany

Platform
  • OPTISOLV® Technology
  • Ingredients
  • Applications
  • Whitepaper
Company
  • About us
  • Team
  • Careers
  • Newsroom
  • Press
Contact
  • kontakt@evanium.de
  • +49 941 94554563
  • Request samples
  • LinkedIn
  • Instagram

© EVANIUM Healthcare GmbH. Information intended for industry professionals.

  • Imprint
  • Privacy Policy
  • Accessibility
  • Change privacy settings
  • Privacy settings history
Cover of the EVANIUM whitepaper The Bioavailability Gap

FREE WHITEPAPER

The Bioavailability Gap

How overlooked formulation challenges are constraining innovation across nutraceuticals, with berberine as a case study.

Download the whitepaper